Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Can we define a rehabilitation strategy for cognitive impairment in progressive multiple sclerosis? A critical appraisal.
Nogo Receptor Signaling Restricts Adult Neural Plasticity by Limiting Synaptic AMPA Receptor Delivery.
Antibodies to neural and non-neural autoantigens in Japanese patients with CNS demyelinating disorders.
Propentofylline reverses delayed remyelination in streptozotocin-induced diabetic rats.
[(18)F]-fluorodeoxyglucose-positron emission tomography in patients with active myelopathy.
The molecular physiology of the axo-myelinic synapse.
Frontrunners of T cell activation: Initial, localized Ca2+ signals mediated by NAADP and the type 1 ryanodine receptor.
Stress in Multiple Sclerosis: Review of New Developments and Future Directions.
Brain derived neurotrophic factor in multiple sclerosis: effect of 24 weeks endurance and resistance training.
Adult-onset Krabbe disease presenting with an isolated form of peripheral neuropathy.
Effect of Inhaled Interferon Beta-1a on Carbon Monoxide Transfer Factor in Healthy Volunteers.
Studies in Experimental Autoimmune Encephalomyelitis Do Not Support Developmental Bisphenol A Exposure as an Environmental Factor in Increasing Multiple Sclerosis Risk.
IL-25 prevents T cell-mediated neurotoxicity by decreasing LFA-1 expression.
Magnetic resonance imaging of the cervical spinal cord in multiple sclerosis at 7T.
Internal jugular vein blood flow in multiple sclerosis patients and matched controls.
What do multiple sclerosis patients and their caregivers perceive as unmet needs?
Increased IL-17A but Decreased IL-27 Serum Levels in Patients with Multiple Sclerosis.
Microbial view of central nervous system autoimmunity.
Rituximab for tumefactive demyelination refractory to corticosteroids and plasma exchange.
Confirmed Disability Improvement In Patients With Active Multiple Sclerosis Treated With Fingolimod Versus Brace: A Matched Comparison of Treatments From The Pangaea And Pearl Registry Studies.
Restless legs syndrome in multiple sclerosis.
The role of KIR2DS1 in multiple sclerosis: KIR in Portuguese MS patients.
[Vaccines and central nervous system demyelinating diseases: New studies on the internet –not just new rumors].
The Severity of Bowel Dysfunction in Patients with Neurogenic Bladder.
Pregnancy Does Not Prove Neuroprotective for Women with MS Who Stop Taking Natalizumab
Pages
« first
‹ previous
…
481
482
483
484
485
486
487
488
489
…
next ›
last »